Collectively, our data indicate that adoptive CD8+ T cells upon the activation of DC/tumor fusion vaccine and LPS-Nb36 restrict the implanted hepatoma tumors progression in mice by impeding tumor cell proliferation and boosting its apoptosis (Fig. 6B). The gene discussed is CD8A; the disease is hepatocellular carcinoma.